BRIANNE EN: Open Payments
NPI 1477274942 · WATERLOO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 31 payments from 13 companies in 2025. Trend: 2023 $303 · 2024 $921 · 2025 $869
Food & beverage: $758Education: $111
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $201 |
| Teva Pharmaceuticals USA, Inc. | 7 | $190 |
| ABBVIE INC. | 9 | $149 |
| Neurocrine BioSciences, Inc. | 2 | $114 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Alkermes, Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 2 | $29 |
| Lundbeck LLC | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Indivior Inc. | 1 | $19 |
Products named: Auvelity, VRAYLAR, INGREZZA, UZEDY, AUSTEDO XR, HETLIOZ, INVEGA, REXULTI.
Industry payments across NY — which companies pay providers there.
